Loading
NASDAQHealthcareMedical - Devices
Latest quote
$2.64
−$0.11 · -4.00%
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
Previous close
$2.64
−$0.11 · -4.00%
Regular session · ET · Market data may be delayed.
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
Day range
Current $2.64
52-week range
Current $2.64
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Hold
Wait — insufficient conviction to act
Valuation
65
Undervalued
Sentiment
51
Mixed
Risk
66
High Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
Day range
Current $2.64
52-week range
Current $2.64
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18.93M USD | 4.88M USD | 40.36K USD | — | 365.15K USD |
| Cost of goods sold | 10.34M USD | 2.24M USD | 134.99K USD | — | 260.57K USD |
| Gross profit | 8.58M USD | 2.64M USD | −94.63K USD | — | 104.58K USD |
| Research and development | 3.94M USD | 3.27M USD | 1.49M USD | — | 2.16M USD |
| Selling, general, and administrative | 9.09M USD | 11.55M USD | 3.43M USD | 4.28M USD | 4.99M USD |
| Operating expenses | 13.02M USD | 14.82M USD | 4.91M USD | 4.28M USD | 7.15M USD |
| Interest income | — | — | 1.53M USD | 1.63M USD | — |
| Interest expense | 2.64M USD | 4.5M USD | 544.83K USD | 23.1K USD | 192.96K USD |
| Depreciation and amortization | 131K USD | 230.8K USD | 480.69K USD | — | 950.73K USD |
| Operating income | −4.44M USD | −12.18M USD | −5.01M USD | −4.28M USD | −7.04M USD |
| Net income | −21.08M USD | −8.98M USD | −6.1M USD | −2.77M USD | −5.42M USD |
Company facts updated Sep 6, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
